Navigation Links
Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs
Date:12/9/2009

ARLINGTON, Va., Dec. 9 /PRNewswire-USNewswire/ -- John M. Gray, President and Chief Executive Officer of the Healthcare Distribution Management Association (HDMA), issued the following statement in reaction to Senate Amendment 2793 to the Patient Protection and Affordable Care Act, which would allow for importation of prescription medications:

"Importation of prescription drugs from foreign countries, as Senator Dorgan and others propose to allow, would compromise the secure U.S. distribution system by increasing the likelihood of entry for counterfeit or adulterated medicines. Efforts to sell counterfeit or adulterated medications produced overseas have become far more sophisticated in just the past few years. Rather than exposing U.S. patients to such risks, Congress should enhance the safety and security of the domestic supply chain through enactment of a uniform federal pedigree standard.

"We are very concerned about provisions in the legislation which call for implementation of a track-and-trace system by 2012. While this effort to address patient safety is well-intentioned, it is not aligned with industry capabilities, technological developments, or federal guidance on product serialization. States that have looked at track-and-trace issues in depth understand the complexity of such an undertaking. That is why the most aggressive time horizons established by states for track-and-trace implementation begin in 2015.

"HDMA and its members support the enhancement of pharmaceutical supply chain security through establishment of a uniform federal pedigree standard. This would facilitate the flow of prescription medicines between states and enable manufacturers, distributors, pharmacies, regulators and law enforcement to identify and prevent the entry of illicit products into our drug supply.

"Before opening our borders, a realistic, comprehensive approach is needed to counter these threats, facilitate interstate commerce and reconcile inconsistencies among the patchwork of state requirements currently in place. Importation is and will be an unsound policy until these issues are addressed."

To learn more about HDMA's position on importation, health reform and other issues, visit www.healthcaredistribution.org.

About HDMA
HDMA is the national association representing primary healthcare distributors, the vital link in the healthcare system. Each business day, HDMA member companies ensure that more than nine million prescription medicines and healthcare products are safely delivered to more than 165,000 pharmacies, hospitals, nursing homes, physician offices, clinics and others nationwide. HDMA and its members work daily to provide value and contain costs, saving the nation's healthcare system an estimated $32 billion per year. For more information, visit www.HealthcareDistribution.org.

SOURCE Healthcare Distribution Management Association


'/>"/>
SOURCE Healthcare Distribution Management Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment
2. Natural Products Association Issues Statement on DEAs Steroid Classification Action
3. AAHSA Statement on Passage of Bennet Health Reform Amendment
4. Natural Products Association Issues Statement on New Supplement Safety Campaign
5. Statement of Support: Strengthening Oral Health Care is Key Part of Health Reform
6. Democratic National Committee Chairman Tim Kaines Statement on the Senates Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation
7. Statement by the Scientific Advisory Board of the Patient Advocate Foundation/National Patient Advocate Foundation on Changes to the USPSTF Mammography Guidelines
8. Pelosi Statement on House Passage of Medicare Physician Payment Reform Act
9. Democratic National Committee Chairman Issues Statement Praising the Patient Protection and Affordable Care Act
10. Statement of Robert Greenstein, Executive Director, Center on Budget and Policy Priorities, on the New Senate Health Reform Bill
11. Pelosi Statement on Senate Health Insurance Reform Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: